Katona C L
Department of Psychiatry, University College London Medical School, UK.
Gerontology. 1994;40 Suppl 1:5-9. doi: 10.1159/000213613.
Depression in old age is common, underdiagnosed and undertreated. It has a high rate of recurrence and is associated with significantly increased mortality. Its mismanagement stems in large part from the misconceptions that it is an inevitable condition, that old people are too inflexible to change, and that treatment is unacceptably hazardous. There is considerable potential for prevention, improved detection and appropriate treatment. In addition, it is increasingly clear that treatment can improve prognosis. Prevention requires education, and a political agenda to address aetiological factors such as poverty, loneliness, institutionalisation and poor physical health. Treatment with antidepressant drugs and/or psychological techniques is effective. Newer drugs may well be superior in safety and real-life tolerability but require better evaluation in representative samples, against placebo and incorporating cost-benefit and quality-of-life measures. Prophylaxis with antidepressants, electroconvulsive therapy and psychotherapy groups has been shown to be effective. The prophylactic efficacy of newer antidepressants has yet to be properly evaluated.
老年抑郁症很常见,诊断不足且治疗不充分。其复发率高,且与死亡率显著增加相关。对其管理不善很大程度上源于一些误解,即认为这是一种不可避免的状况、老年人过于僵化而无法改变、治疗存在不可接受的风险。预防、改善检测和进行适当治疗有很大潜力。此外,越来越明显的是,治疗可改善预后。预防需要开展教育,并制定政治议程以解决诸如贫困、孤独、机构化生活和身体健康不佳等病因。使用抗抑郁药物和/或心理技术进行治疗是有效的。新型药物在安全性和实际耐受性方面可能更具优势,但需要在代表性样本中与安慰剂进行对照,并纳入成本效益和生活质量衡量指标,以进行更好的评估。已证明使用抗抑郁药、电休克疗法和心理治疗组进行预防是有效的。新型抗抑郁药的预防效果尚未得到恰当评估。